Nancy Stirling, DO
Family Medicine · Bedford, INNPI 1881784510
Payments from drug & device makers
Across 17 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$66
- Novo Nordisk$38
- Exact Sciences$36
- AstraZeneca$29
- Lundbeck LLC$23
- Axsome Therapeutics, Inc.$20
- plus $98 from 6 others
What the payments were for
- Food & beverage$310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Novo Nordisk | 2 | $38 |
| Exact Sciences | 2 | $36 |
| AstraZeneca | 2 | $29 |
| Lundbeck LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| AbbVie | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Merck | 1 | $14 |
How this compares
$310 in reported general payments places this provider in the 40th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,274 |
| Diclofenac Sodium | 22 | $873 |
| Liothyronine Sodium | 11 | $780 |
| Celecoxib | 13 | $696 |
| Duloxetine Hcl | 20 | $691 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $639 |
| Gabapentin | 67 | $602 |
| Levothyroxine Sodium | 91 | $573 |
| Omeprazole | 38 | $489 |
| Metoprolol Succinate | 30 | $358 |
| Tizanidine Hcl | 16 | $303 |
| Alendronate Sodium | 11 | $272 |
| Cyclobenzaprine Hcl | 27 | $252 |
| Escitalopram Oxalate | 16 | $226 |
| Amlodipine Besylate | 54 | $207 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bedford
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.